Disease Learning

Disease Learning

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss a frail patient with metastatic squamous NSCLC with low tumor PD-L1 expression, and the best treatment approach for this patient.
Cancer Journey:
Cancer Type:
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss treating a patient with rapidly progressing lung adenocarcinoma and high tumor PD-L1 expression.
Cancer Journey:
Cancer Type:
Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, gathered post meeting to discuss new information from ASCO 2018 regarding head and neck cancers.
Cancer Journey:
Cancer Type:
Disease Learning:
Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, gathered post meeting to discuss new information from ASCO 2018 regarding head and neck cancers.
Cancer Journey:
Cancer Type:
Disease Learning:
Drs. Jared Weiss and Josh Bauml, gathered post ASCO 2018 to discuss new information regarding head and neck cancers. In this roundtable video, the doctors discuss mucositis.
Cancer Journey:
Cancer Type:
Disease Learning:

Articles

Head & Neck Cancers Frequently Asked Questions Written by Joshua Bauml, MD September 2017 What is it? “Head and neck cancer” is an umbrella term...
Cancer Journey:
Cancer Type:
Disease Learning:
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Cancer Type:
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
Cancer Journey:
Cancer Type:
Disease Learning:
GRACE is excited to continue to build the faculty and agenda for the upcoming Targeted Therapies Patient Forum, September 16, 2017. See more information about our presenters in Speaker Highlights - today we introduce James Stevenson, MD.
Cancer Journey:
Cancer Type:
Disease Learning:
Christine M. Walko, Pharm.D., discusses how advancements in technology have improved the quality, cost and turnaround time for assessing genetic mutations in tumor tissue, and how this has helped to translate precision medicine into standard clinical practice.
Cancer Journey:
Cancer Type:
Disease Learning:

Community Forum

Hello GRACE members, To post a new question in the forums, click on "Participate" in the menu bar near the top of the page. When the new page appears...
Cancer Journey:
Cancer Type:
Disease Learning:
Mother-in-Law was diagnosed with NSCLC and after a blood biopsy, doctor is recommending Osimertinib. I tried searching on the main page, but it wasn'...
Cancer Journey:
Cancer Type:
GRACE would like to start conversations about other types of Cancers! We are hopeful to begin providing the same great information for Head and Neck...
Cancer Journey:
Cancer Type:
Disease Learning:
Wondering if anyone has info on compatibility of berberine with Tarceva. I called Genentech but they didn’t know. I am taking it because it has...
Cancer Journey:
Cancer Type:
Disease Learning:
Well, here we are, barring any last minute complications my wife should start the TAK-788 trial next week. She has already had her main blood work...
Cancer Journey:
Cancer Type:
Disease Learning: